COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 10 Oct 2024)
What this means for you
Registered since 07 Aug 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87646713
- Registration number
- 5533589
- Mark type
- Design + words
- Filed
- 16 Oct 2017
- Published for opposition
- 22 May 2018
- Registered
- 07 Aug 2018
- Attorney of record
- Laurence Rickles
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparation for use in human medicine for the treatment of multiple sclerosis containing glatiramer acetate
Owner
- Teva Pharmaceutical Industries Limited, Petach Tikva, IL
- Teva Pharmaceutical Industries Limited, Jerusalem, IL
- Teva Pharmaceutical Industries Limited, Jerusalem, IL
Prosecution history
- 10 Oct 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 10 Oct 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 10 Oct 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Apr 2024 — TEAS SECTION 8 & 15 RECEIVED
- 07 Aug 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 Aug 2018 — REGISTERED-PRINCIPAL REGISTER
- 22 May 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 May 2018 — PUBLISHED FOR OPPOSITION
- 02 May 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Apr 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Apr 2018 — EXAMINER'S AMENDMENT ENTERED
- 18 Apr 2018 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 18 Apr 2018 — EXAMINERS AMENDMENT E-MAILED
- 18 Apr 2018 — EXAMINERS AMENDMENT -WRITTEN
- 09 Apr 2018 — PREVIOUS ALLOWANCE COUNT WITHDRAWN